Azinyl-3-sulfonylindazole derivatives as 5-hydroxytryptamine-6 ligands

The present invention provides a compound of formula I and the use thereof for the treatment of a central nervous system disorder related to or affected by the 5-HT6 receptor.

Saved in:
Bibliographic Details
Main Authors Elokdah, Hassan Mahmoud, Greenfield, Alexander Alexei, Liu, Kevin, McFarlane, Geraldine Ruth, Grosanu, Cristina, Lo, Jennifer Rebecca, Robichaud, Albert Jean
Format Patent
LanguageEnglish
Published 07.09.2010
Online AccessGet full text

Cover

More Information
Summary:The present invention provides a compound of formula I and the use thereof for the treatment of a central nervous system disorder related to or affected by the 5-HT6 receptor.